Biodol Therapeutics

Pharmaceutical Manufacturing • Montarnaud, Occitanie, France • 1-10 Employees

Company overview

Headquarters	165 rue Denis Papin, Montarnaud, 34570, FR
Website	biodol.eu
NAICS	3254
Founded	2015
Employees	1-10
Socials

Key Contacts at Biodol Therapeutics

Fabien Granier

Ceo - Cofounder

Pierre Sokoloff

Chief Scientific Officer -Cofounder

Biodol Therapeutics Email Formats

Biodol Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@biodol.eu), used 66.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@biodol.eu	66.7%
{first name}.{last name}	john.doe@biodol.eu	33.3%

About Biodol Therapeutics

BIODOL Therapeutics is a biotech company developing first-in-class compounds for treating chronic pain. It is based on the discovery by Biodol's scientists of the target FLT3, which is a master hub protein in the initiation and maintenance of neuropathic pain (Nature Communications 2018). Morevover, Biodol discovered that its FLT3 breakthrough platform will also help fighting the "Opioid Crisis" (patented but yet unpublished). Biodol has a series of FLT3 selective small-molecule extracellular antagonists. The Biodol's FLT3 technological Platform is worldwide protected by 5 patents.

Biodol Therapeutics revenue & valuation

Annual revenue	$1,500,000
Revenue per employee	$215,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$4,800,000
Total funding	$20,600,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Founder/Owner

Employees by Department

Biodol Therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Biodol Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2020-10-01	4	$5,400,000
2024-06-21	9	$7,600,000
2024-06-21	15	$7,600,000

Funding Insights

$20,600,000

Total funding amount

$7,600,000

Most recent funding amount

Number of funding rounds

Biodol Therapeutics Tech Stack

Discover the technologies and tools that power Biodol Therapeutics's digital infrastructure, from frameworks to analytics platforms.

OVHcloud

Hosting

Modernizr

JavaScript libraries

Font Awesome

Font scripts

jQuery

JavaScript libraries

Frequently asked questions

Biodol Therapeutics is located in Montarnaud, Occitanie, FR.

Biodol Therapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Biodol Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Biodol Therapeutics has raised a total of $20,600,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Biodol Therapeutics

Fabien Granier

Ceo - Cofounder

Pierre Sokoloff

Chief Scientific Officer -Cofounder

4.8

40,000 users